Therapie 1990-01-01

[Acute toloxatone poisoning. Apropos of 122 cases].

P Azoyan, R Garnier, F J Baud, M L Efthymiou

Index: Therapie. 45(2) , 139-44, (1990)

Full Text: HTML

Abstract

Toloxatone is a new monoamine oxidase inhibitor. One hundred and twenty two cases of poisoning with this drug are reported. In this series, the minimal toxic dose was 2 g. The first symptoms appeared about one hour after ingestion. In most cases, only drowsiness and mild adrenergic effects were observed. In a few cases of massive overdose, coma, pyramidal irritation, and myoclonic jerks occurred. In 3 cases of severe poisoning, toloxatone was associated with tricyclic antidepressants. Symptoms were similar to those reported in intoxications associating classical monoamine oxidase inhibitors and tricyclic antidepressants: muscular rigidity, hyperthermia and cardiovascular collapse. Two of these patients died.

Related Compounds

Related Articles:

5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO).

2014-01-01

[Drug Test. Anal. 6(7-8) , 607-13, (2014)]

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

2015-05-01

[J. Pharmacol. Exp. Ther. 356 , 483-92, (2016)]

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder.

1992-01-01

[Psychopharmacology 106 Suppl , S118-9, (1992)]

Minor and clinically non-significant interaction between toloxatone and amitriptyline.

1993-01-01

[Eur. J. Clin. Pharmacol. 44(1) , 97-9, (1993)]

Effect of acute ethanol administration on toloxatone pharmacokinetics in rabbits.

1999-05-01

[Alcohol. Clin. Exp. Res. 23(5) , 885-90, (1999)]

More Articles...